(Q40041145)
Statements
First in human phase I trial of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced cancer (English)
Arkadiusz Z Dudek
Carla Yunis
Lester I Harrison
Sandeep Kumar
Ronald Hawkinson
John P Vasilakos
1 December 2007